Recent studies have shown that the activation of CB1R by minor phytocannabinoids exerts anti-arthritis activity in murine models, highlighting its potential for the treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA) [12]. This evidence concerns the gene CNR1 and rheumatoid arthritis.